Cargando…

ERK mediates interferon gamma-induced melanoma cell death

BACKGROUND: Interferon-gamma (IFNγ) exerts potent growth inhibitory effects on a wide range of cancer cells through unknown signaling pathways. We pursued complementary screening approaches to characterize the growth inhibition pathway. METHODS: We performed chemical genomics and whole genome target...

Descripción completa

Detalles Bibliográficos
Autores principales: Champhekar, Ameya, Heymans, Rachel, Saco, Justin, Turon Font, Guillem, Gonzalez, Cynthia, Gao, Anne, Pham, John, Lee, June, Maryoung, Ryan, Medina, Egmidio, Campbell, Katie M., Karin, Daniel, Austin, David, Damioseaux, Robert, Ribas, Antoni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557262/
https://www.ncbi.nlm.nih.gov/pubmed/37803324
http://dx.doi.org/10.1186/s12943-023-01868-x
Descripción
Sumario:BACKGROUND: Interferon-gamma (IFNγ) exerts potent growth inhibitory effects on a wide range of cancer cells through unknown signaling pathways. We pursued complementary screening approaches to characterize the growth inhibition pathway. METHODS: We performed chemical genomics and whole genome targeting CRISPR/Cas9 screens using patient-derived melanoma lines to uncover essential nodes in the IFNγ-mediated growth inhibition pathway. We used transcriptomic profiling to identify cell death pathways activated upon IFNγ exposure. Live imaging experiments coupled with apoptosis assays confirmed the involvement of these pathways in IFNγ-mediated cell death. RESULTS: We show that IFNγ signaling activated ERK. Blocking ERK activation rescued IFNγ-mediated apoptosis in 17 of 23 (~ 74%) cell lines representing BRAF, NRAS, NF1 mutant, and triple wild type subtypes of cutaneous melanoma. ERK signaling induced a stress response, ultimately leading to apoptosis through the activity of DR5 and NOXA proteins. CONCLUSIONS: Our results provide a new understanding of the IFNγ growth inhibition pathway, which will be crucial in defining mechanisms of immunotherapy response and resistance. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12943-023-01868-x.